Bank Of America Corp Sarepta Therapeutics, Inc. Call Options Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $2.86 Million - $3.61 Million	-23,000 Reduced 77.18%	6,800 $849,000
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $7.84 Million - $11.3 Million	-69,200 Reduced 69.9%	29,800 $4.71 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $9.28 Million - $14 Million	99,000 New	99,000 $12.8 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $7.23 Million - $9.59 Million	61,500 New	61,500 $8.48 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $1.2 Million - $1.69 Million	19,100 New	19,100 $1.43 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.